quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 17, 2026

Prediction: The Trump Bull Market Will Come to an Abrupt End Because of 2 Decisions Made by the President

View original at nasdaq.com
Prediction: The Trump Bull Market Will Come to an Abrupt End Because of 2 Decisions Made by the President Key Points The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite have all soared with Donald Trump in the White House…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Kevin Warsh's FOMC voting record shows he consistently favored price stability and higher interest rates even as the unemployment rate soared during the financial crisis, earning him the label of 'hawk'

    60% confidence
  • A $1,000 investment in Nvidia at the time of the April 15, 2005 Stock Advisor recommendation would now be worth $1,381,332

    60% confidence
  • Gas accounts for 3.1% of the average American household budget but can be a considerably larger share of monthly expenditures for low-income households

    60% confidence
  • Cleveland Fed's Inflation Nowcasting tool projects U.S. TTM inflation of 3.89% in May 2026

    60% confidence
  • Annualized stock market returns under Trump are notably higher than under most other presidents

    60% confidence
  • The Iran war is on track to increase U.S. TTM inflation by nearly 150 basis points between February and May 2026

    60% confidence
  • Kevin Warsh is not easy on inflation; Trump got the wrong person for Fed Chair if he wanted someone accommodative

    60% confidence
  • A $1,000 investment in Netflix at the time of the December 17, 2004 Stock Advisor recommendation would now be worth $469,293

    60% confidence
  • Kevin Warsh's influence as Fed Chair, combined with three FOMC members opposing an easing bias in April 2026, points to a growing likelihood of a shift toward neutral or hiking monetary policy bias

    60% confidence
  • The effect of higher energy prices on businesses often lags a few months, meaning Iran war-driven transportation and production cost increases will push inflation further when they appear in economic data

    60% confidence
  • Iran shutting down the Strait of Hormuz represents the largest energy supply disruption in modern history, placing 20 million barrels of petroleum liquids per day into limbo and adversely affecting 20% of world crude oil demand

    60% confidence
  • Rapidly rising inflation from the Iran war, paired with a hawkish Fed Chair and a historically pricey stock market, is a recipe for disaster for the Dow Jones, S&P 500, and Nasdaq Composite

    60% confidence
  • Average U.S. gas prices per gallon on May 6 per AAA: Regular $4.54 (up $1.56 since Iran war began Feb 28), Premium $5.39 (up $1.85), Diesel $5.67 (up $1.81)

    60% confidence
  • Gas prices have soared at the fastest pace in over 30 years due to the Iran war

    60% confidence
  • The Trump bull market will come to an abrupt end because of two presidential decisions: the military campaign against Iran and the appointment of hawkish Kevin Warsh as Fed Chair

    60% confidence
  • The S&P 500 or Dow Jones has advanced in 26 of the last 33 presidential terms dating back to 1896

    60% confidence

Data points we hold from this source

S&P 500 Index Fund · total return stock advisor benchmark comparison207 percent
S&P 500 Index Fund · presidential term advance rate26 of_33_terms
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com